Peregrine Capital Management LLC Has $5.25 Million Position in Cabot Corporation $CBT

Peregrine Capital Management LLC grew its holdings in Cabot Corporation (NYSE:CBT) by 24.7% during the 4th quarter, HoldingsChannel reports. The firm owned 79,148 shares of the specialty chemicals company’s stock after acquiring an additional 15,669 shares during the quarter. Peregrine Capital Management LLC’s holdings in Cabot were worth $5,246,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Farther Finance Advisors LLC grew its position in shares of Cabot by 9.6% in the fourth quarter. Farther Finance Advisors LLC now owns 1,873 shares of the specialty chemicals company’s stock valued at $124,000 after purchasing an additional 164 shares during the last quarter. Gabelli Funds LLC grew its position in shares of Cabot by 1.3% in the third quarter. Gabelli Funds LLC now owns 13,570 shares of the specialty chemicals company’s stock valued at $1,032,000 after purchasing an additional 180 shares during the last quarter. First Citizens Bank & Trust Co. grew its position in shares of Cabot by 1.4% in the third quarter. First Citizens Bank & Trust Co. now owns 14,558 shares of the specialty chemicals company’s stock valued at $1,107,000 after purchasing an additional 206 shares during the last quarter. Hantz Financial Services Inc. grew its position in shares of Cabot by 227.5% in the third quarter. Hantz Financial Services Inc. now owns 429 shares of the specialty chemicals company’s stock valued at $33,000 after purchasing an additional 298 shares during the last quarter. Finally, Smartleaf Asset Management LLC grew its position in shares of Cabot by 598.0% in the third quarter. Smartleaf Asset Management LLC now owns 349 shares of the specialty chemicals company’s stock valued at $27,000 after purchasing an additional 299 shares during the last quarter. 93.18% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on CBT shares. Mizuho set a $75.00 target price on shares of Cabot and gave the company a “neutral” rating in a research note on Wednesday, February 4th. Zacks Research upgraded shares of Cabot from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 27th. Jefferies Financial Group reiterated a “buy” rating and issued a $85.00 target price on shares of Cabot in a research note on Wednesday, February 4th. UBS Group increased their target price on shares of Cabot from $74.00 to $81.00 and gave the company a “neutral” rating in a research note on Thursday, February 5th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Cabot in a research note on Monday, December 29th. One analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $73.75.

Cabot Stock Up 1.1%

NYSE CBT opened at $76.27 on Friday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.09 and a current ratio of 1.67. The firm has a 50-day simple moving average of $73.48 and a 200 day simple moving average of $70.02. Cabot Corporation has a twelve month low of $58.33 and a twelve month high of $83.71. The stock has a market cap of $3.98 billion, a PE ratio of 13.36, a PEG ratio of 9.94 and a beta of 0.84.

Cabot (NYSE:CBT) last released its earnings results on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.13. Cabot had a net margin of 8.62% and a return on equity of 22.82%. The business had revenue of $849.00 million during the quarter, compared to analysts’ expectations of $889.11 million. During the same quarter last year, the company earned $1.76 earnings per share. The firm’s revenue was down 11.1% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. On average, research analysts forecast that Cabot Corporation will post 6.27 EPS for the current year.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.